Tryton Medical, Inc. Announces Successful Live Case Transmission at TCT Conference in San Francisco
11/10/2011 11:22:05 AM
SAN FRANCISCO & DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the transmission of a live satellite feed of a clinical case using the Tryton stent to an audience of several hundred interventional cardiologists at the annual Transcatheter Cardiovascular Therapeutics (TCT) 2011 Conference in San Francisco.
comments powered by